National Institutes of Health

NIH: Accelerating Medicines Partnership (AMP) in Rheumatoid Arthritis and Lupus: Network Leadership Center (UM2)

Program Summary

The purpose of this FOA is to solicit applications for the Accelerating Medicines Partnership (AMP) in Rheumatoid Arthritis (RA) and Lupus Network Leadership Center. The AMP RA and Lupus Network is designed to ascertain and define shared and disease-specific biological pathways in order to identify relevant drug targets for the treatment of autoimmune diseases. This program will involve an enhanced systems-level understanding of gene expression and signaling in target tissues from affected end organs and peripheral blood cells.

Eligibility

Only one application per institution is allowed. 

Award Information

Cooperative agreement.  NIH intends to commit up to $1.4 million in total costs in FY 2014 to fund one award.  Application budgets are limited to $2 million per year in total costs for years one and two, and are limited to $3 million per year in years three, four and five.   The total project period may not exceed five years.

Please contact Angie Robertson (angie-robertson@uiowa.edu / 353-3619), in the Carver College of Medicine, if you are interested in participating in this opportunity. 

Date Due to DSP or UIF05/14/2014
Date Due to Sponsor05/21/2014
Required LOI Due DateN/A
Non-Required LOI Due Date04/21/2014
Email:angie-robertson@uiowa.edu
Phone:319-353-3619
Sponsor URL:http://grants.nih.gov/grants/guide/rfa-files/RFA-AR-14-015.html

Admin/Reviewer Login here first

Back to the WINS main page